Cite Filings / RCUS / 0000902664-25-005004

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Arcus Biosciences, Inc. Filed 2025-11-14 Acc 0000902664-25-005004

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-01-08 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-19 4 President sold 50,000 shares at an average $20.26 ($1,012,764)
2025-11-17 144 Sale of Securities
2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-12 4 Chief Operating Officer sold 50,291 shares at $18.97 ($954,066)
2025-04-17 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…